Adjuvant Toripalimab Better Tolerated Than HDI in Mucosal Melanoma
Toripalimab is similarly effective but safer than high-dose interferon-α2b for patients with resected mucosal melanoma, a new study suggests.
Toripalimab is similarly effective but safer than high-dose interferon-α2b for patients with resected mucosal melanoma, a new study suggests.
Readers most accurately discriminated between thin (≤1.0 mm) and thick melanomas (>1.0 mm).
From 2010 to 2019, the percentage of oncology practices with medically integrated dispensing more than doubled.
A decision-analytic study sought to identify an effective model for predicting risk for SLN biopsy and metastasis in patients with cutaneous melanoma.
Younger age, female sex, increased disease severity, and having a significant other to help with exams may improve compliance.
Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.